Cargando…
PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429643/ http://dx.doi.org/10.1097/01.HS9.0000975004.91980.ef |
_version_ | 1785090765562576896 |
---|---|
author | Lee, Hyuna Park, Jihye Jang, Hyerin Kim, Jungryul |
author_facet | Lee, Hyuna Park, Jihye Jang, Hyerin Kim, Jungryul |
author_sort | Lee, Hyuna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104296432023-08-17 PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB Lee, Hyuna Park, Jihye Jang, Hyerin Kim, Jungryul Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429643/ http://dx.doi.org/10.1097/01.HS9.0000975004.91980.ef Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Lee, Hyuna Park, Jihye Jang, Hyerin Kim, Jungryul PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title_full | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title_fullStr | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title_full_unstemmed | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title_short | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
title_sort | pb2051: population pharmacokinetic/pharmacodynamic/efficacy modeling of sb12 (proposed eculizumab biosimilar) and reference eculizumab |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429643/ http://dx.doi.org/10.1097/01.HS9.0000975004.91980.ef |
work_keys_str_mv | AT leehyuna pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT parkjihye pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT janghyerin pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT kimjungryul pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab |